Conor M. Lewis, Thomas A. Waigh*, Anna M. Stephens, Jian R. Lu, Charles T. Heise, Natalia Harasimiuk and Jennifer Tovey,
{"title":"低pH条件下单克隆抗体凝胶化过程的微流变学研究。","authors":"Conor M. Lewis, Thomas A. Waigh*, Anna M. Stephens, Jian R. Lu, Charles T. Heise, Natalia Harasimiuk and Jennifer Tovey, ","doi":"10.1021/acs.molpharmaceut.5c00220","DOIUrl":null,"url":null,"abstract":"<p >Non-native aggregation of monoclonal antibodies (mAbs) during downstream processing can reduce their efficacy (e.g., in immunotherapies) and the total yield. The pH of mAb solutions was lowered, similar to steps during viral inactivation and protein A chromatography, and a continuous phase transition to a physically cross-linked gel was observed via microrheology. The dynamic power-law scaling of the shear modulus on the frequency, <i>G′</i>(ω) ∝ <i>G</i>″(ω) ∝ ω<sup><i>n</i></sup>, was calculated using time-cure superposition, yielding a dynamical critical exponent, <i>n</i> = 0.52 ± 0.05. Dynamic light scattering showed a similar power law scaling exponent of μ = 0.49 ± 0.04 about the gel point which is related to the fractal dimension. Circular dichroism showed large increases in the β-sheet content of the mAbs at low pHs combined with a large increase in fluorescence of a ThT stained sample. Thus, mAb gelation seems to occur via the formation of amyloid fibrils that cause a continuous phase transition that is well described by a dynamic scaling model for percolation.</p>","PeriodicalId":52,"journal":{"name":"Molecular Pharmaceutics","volume":"22 8","pages":"4624–4631"},"PeriodicalIF":4.5000,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Microrheology of Monoclonal Antibodies during Gelation under Low pH Conditions\",\"authors\":\"Conor M. Lewis, Thomas A. Waigh*, Anna M. Stephens, Jian R. Lu, Charles T. Heise, Natalia Harasimiuk and Jennifer Tovey, \",\"doi\":\"10.1021/acs.molpharmaceut.5c00220\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >Non-native aggregation of monoclonal antibodies (mAbs) during downstream processing can reduce their efficacy (e.g., in immunotherapies) and the total yield. The pH of mAb solutions was lowered, similar to steps during viral inactivation and protein A chromatography, and a continuous phase transition to a physically cross-linked gel was observed via microrheology. The dynamic power-law scaling of the shear modulus on the frequency, <i>G′</i>(ω) ∝ <i>G</i>″(ω) ∝ ω<sup><i>n</i></sup>, was calculated using time-cure superposition, yielding a dynamical critical exponent, <i>n</i> = 0.52 ± 0.05. Dynamic light scattering showed a similar power law scaling exponent of μ = 0.49 ± 0.04 about the gel point which is related to the fractal dimension. Circular dichroism showed large increases in the β-sheet content of the mAbs at low pHs combined with a large increase in fluorescence of a ThT stained sample. Thus, mAb gelation seems to occur via the formation of amyloid fibrils that cause a continuous phase transition that is well described by a dynamic scaling model for percolation.</p>\",\"PeriodicalId\":52,\"journal\":{\"name\":\"Molecular Pharmaceutics\",\"volume\":\"22 8\",\"pages\":\"4624–4631\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2025-07-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular Pharmaceutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.5c00220\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.5c00220","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
Microrheology of Monoclonal Antibodies during Gelation under Low pH Conditions
Non-native aggregation of monoclonal antibodies (mAbs) during downstream processing can reduce their efficacy (e.g., in immunotherapies) and the total yield. The pH of mAb solutions was lowered, similar to steps during viral inactivation and protein A chromatography, and a continuous phase transition to a physically cross-linked gel was observed via microrheology. The dynamic power-law scaling of the shear modulus on the frequency, G′(ω) ∝ G″(ω) ∝ ωn, was calculated using time-cure superposition, yielding a dynamical critical exponent, n = 0.52 ± 0.05. Dynamic light scattering showed a similar power law scaling exponent of μ = 0.49 ± 0.04 about the gel point which is related to the fractal dimension. Circular dichroism showed large increases in the β-sheet content of the mAbs at low pHs combined with a large increase in fluorescence of a ThT stained sample. Thus, mAb gelation seems to occur via the formation of amyloid fibrils that cause a continuous phase transition that is well described by a dynamic scaling model for percolation.
期刊介绍:
Molecular Pharmaceutics publishes the results of original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. The journal encourages contributions describing research at the interface of drug discovery and drug development.
Scientific areas within the scope of the journal include physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science as they relate to drug and drug delivery system efficacy. Mechanistic Drug Delivery and Drug Targeting research on modulating activity and efficacy of a drug or drug product is within the scope of Molecular Pharmaceutics. Theoretical and experimental peer-reviewed research articles, communications, reviews, and perspectives are welcomed.